Attached files
| file | filename |
|---|---|
| EX-23.1 - EXHIBIT 23.1 - ANAPTYSBIO, INC | anab-123119xexx231.htm |
| EX-32.1 - EXHIBIT 32.1 - ANAPTYSBIO, INC | anab-123119x10kxexx321.htm |
| EX-31.2 - EXHIBIT 31.2 - ANAPTYSBIO, INC | anab-123119x10kxexx312.htm |
| EX-31.1 - EXHIBIT 31.1 - ANAPTYSBIO, INC | anab-123119x10kxexx311.htm |
| EX-21.1 - EXHIBIT 21.1 - ANAPTYSBIO, INC | anab-123119xexx211.htm |
| EX-4.3 - EXHIBIT 4.3 - ANAPTYSBIO, INC | anaptys-10xkfy2019xexh.htm |
| 10-K - 10-K - ANAPTYSBIO, INC | anab-12311910k.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Eric Loumeau, Interim Chief Financial Officer of AnaptysBio, Inc. (Company), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
• | the Annual Report on Form 10-K of the Company for the year ended December 31, 2019 (the “Report”), as filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
• | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented therein. |
Date: March 2, 2020
/s/ Eric Loumeau |
Eric Loumeau |
Interim Chief Financial Officer and General Counsel |
(Principal Financial Officer) |